These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21722687)

  • 21. [Control of hepatitis B in French Polynesia with a program of systematic vaccination of newborns with the Genhevac B vaccine].
    Moulia-Pelat JP; Spiegel A; Excler JL; Martin P; Roux JF; Boutin JP; Blondeau C; Saliou P
    Sante; 1996; 6(1):11-5. PubMed ID: 8612008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative vaccination for HBV at Polish hospitals as a possible public health tool to limit the spread of the epidemic: a cross-sectional study.
    Ganczak M; Szych Z; Korzeń M
    Vaccine; 2009 Jun; 27(30):3969-74. PubMed ID: 19389444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface antibody and cytokine response to recombinant Chinese hamster ovary cell (CHO) hepatitis B vaccine.
    Zhang W; Han L; Lin C; Wang H; Pang X; Li L; Gao P; Lin H; Gong X; Tang Y; Ma J; Zhang H; Wang C; Yang P; Li H; Sun M; He X
    Vaccine; 2011 Aug; 29(37):6276-82. PubMed ID: 21722684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan.
    Lu SN; Chen CH; Chen TM; Lee PL; Wang JH; Tung HD; Hung CH; Lee CM; Changchien CS
    Vaccine; 2006 Feb; 24(6):759-65. PubMed ID: 16159687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B marker seroprevalence and vaccination coverage in adolescents in the City of Itajaí, State of Santa Catarina, Southern Brazil, in 2008.
    Tonial GC; Passos AM; Livramento Ad; Scaraveli NG; Batschauer AP; Bueno EC; Largura A; Spada C; Treitinger A
    Rev Soc Bras Med Trop; 2011; 44(4):416-9. PubMed ID: 21860885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-hepatitis B core antibody is not required for prevaccination screening in healthcare workers.
    Shim J; Kim KY; Kim BH; Chun H; Lee MS; Hwangbo Y; Jang JY; Dong SH; Kim HJ; Chang YW; Chang R
    Vaccine; 2011 Feb; 29(8):1721-6. PubMed ID: 21147128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
    Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
    Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of isolated antibody to hepatitis B core antigen in Dutch national vaccination campaign of behavioural high-risk groups.
    Koene RP; Gotz HM; Van Den Hoek JA; Heijnen ML; Van Steenbergen JA; Kroes AC
    Epidemiol Infect; 2009 Apr; 137(4):495-503. PubMed ID: 18647436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term efficacy of the hepatitis B vaccine in a high-risk group.
    Al Ghamdi SS; Fallatah HI; Fetyani DM; Al-Mughales JA; Gelaidan AT
    J Med Virol; 2013 Sep; 85(9):1518-22. PubMed ID: 23852676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody titers and response to vaccination against hepatitis A and B in pediatric patients with portal hypertension.
    Rosa MN; Hessel G; Alves De Tommaso AM
    Acta Gastroenterol Latinoam; 2008 Sep; 38(3):187-93. PubMed ID: 18979898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
    Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
    Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroepidemiology of hepatitis B in Greek children 6 years after the implementation of universal vaccination.
    Papaevangelou V; Hadjichristodoulou C; Cassimos DC; Pantelaki K; Tzivaras A; Hatzimichael A; Theodoridou M
    Infection; 2008 Mar; 36(2):135-9. PubMed ID: 18231718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
    Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM
    J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of accelerated hepatitis B vaccination program in patients being actively treated for hematologic malignancies.
    Pullukcu H; Ertem E; Karaca Y; Yamazhan T; Sertoz RY; Altuglu I
    Int J Infect Dis; 2008 Mar; 12(2):166-70. PubMed ID: 17720599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The vaccination of medical and nursing students against hepatitis B].
    Bayas JM; Bruguera M; Vilella A; Bare ML; Prat A; Vidal J; Pérez L; Asenjo MA; Salleras L
    Med Clin (Barc); 1993 May; 101(1):8-11. PubMed ID: 8315979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological changes in hepatitis B prevalence in an entire population after 20 years of the universal HBV vaccination programme.
    Shen LP; Zhang Y; Wang F; Zhang S; Yang JY; Fang KX; Yu T; Wang XY; Zhang WY; Bi SL
    Epidemiol Infect; 2011 Aug; 139(8):1159-65. PubMed ID: 21156099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.